PainChek Limited (ASX:PCK)

Australia flag Australia · Delayed Price · Currency is AUD
0.2650
-0.0200 (-7.02%)
At close: Jan 22, 2026
-1.85%
Market Cap55.39M
Revenue (ttm)3.36M
Net Income (ttm)-7.67M
Shares Out209.01M
EPS (ttm)-0.04
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume134,350
Average Volume141,984
Open0.2850
Previous Close0.2850
Day's Range0.2650 - 0.2850
52-Week Range0.2500 - 1.0500
Beta0.71
RSI41.45
Earnings DateJan 29, 2026

About PainChek

PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company offers PainChek, a clinically validated and regulatory cleared pain assessment technology that uses cameras in smartphones for a facial scan that is analyzed using facial recognition software to indicate the presence of pain. It serves patients suffering with dementia and pre-verbal infants; and the aged care, disability, home care, hospital, and infant s... [Read more]

Sector Healthcare
CEO Philip Daffas
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol PCK
Full Company Profile

Financial Performance

In 2025, PainChek's revenue was 3.36 million, an increase of 25.84% compared to the previous year's 2.67 million. Losses were -7.67 million, -7.65% less than in 2024.

Financial Statements